United States · Biotechnology startup
United States · Alladapt Immunotherapeutics
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Funding reportedLast round: Debt financing
What company datasets say Alladapt Immunotherapeutics raised
Funding, as reported
Reported in all$229Min dollars
Rounds3
Last roundDebt financing
Last round dateAug 2022
Investors listed15
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Alladapt Immunotherapeutics in front of investors. Or tell us what we have wrong.